Korean pharmas developed 9 products of 8 types biosimilars like Remsima

It was reported 9 biologic products of 8 types were developed by Korean pharmaceutical companies, such as Celltrion with the rheumatoid arthritis therapy ‘Remsima Inj.’

According to the Ministry of Food and Drug Safety(MFDS), 13 biosimilar products of total 10 types have been approved in Korea even since they approved ‘Remsima Inj 100mg,’ the world’s first monoclonal biosimilar, in 2012.

In t...